3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$2,170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- HR 1978/S 912, "Protecting Seniors Through Immunization Act", regarding all provisions - HR 6007, "To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes", regarding all provisions - H.Res. 446, Expressing support for the goals and ideals of National Stroke Awareness Month, regarding all provisions - S 610/HR 1667, "The Dr. Lorna Breen Health Care Provider Protection Act", regarding all provisions - HR 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - S 1784/HR 3353, Contact Lens Prescription Verification Modernization Act, regarding all provisions - HR 5030/S 2706, "The Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, regarding all provisions - S 3394, "Emergency Use Transparency Act", regarding all provisions - HR 5376, "Build Back Better Act", regarding provisions on drug pricing and provisions related to revenue - HR 3990/S 2047, "No PFAS in Cosmetics Act", regarding all provisions - HR 8299/S 4386, FDA review of certain changes to software in medical devices or predetermined change control plans - HR 7667/S 4348, "Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act", regarding provisions on accelerated approval and diversity in clinical studies - HR 5801, "HELP Copays Act", regarding all provisions - HR 3173/S 3018 - "Improving Seniors Timely Access to Care Act of 2021" - S 3799 - "PREVENT Pandemics Preparedness Act" - HR 3932/S 2079 - "PASTEUR Act of 2021" - HR 5376 - "Inflation Reduction Act", regarding provisions on prescription drugs - Issues related to Dengue - Issues related to prescription drug pricing - Issues related to health care pricing transparency - Issues related to maternal health - Issues related to frontline health workers - Issues related to over the counter products - Issues related to the regulation of cosmetic products - Issues related to the regulation of dietary supplements - Issues related to stroke care - Issues related to counterfeit health care goods - Issues related to 340B drug pricing program - Issues related to antimicrobial resistance - Issues related to the COVID-19 vaccine development, including diversity in clinical trials - Issues related to Medicare Part D's 6 protected classes - Issues related to global public health and ending tuberculosis - Issues pertaining to health equity and social determinants of health - Issues related to FDA medical device shortage reporting requirements, including implementation of CARES Act requirements - Issues related to lung cancer screening - Issues related to clinical research diversity - Issues related to international harmonization of medical device regulation

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th), H.R. 1978 (117th), H.R. 6007 (117th), H.R. 5030 (117th), H.R. 3932 (117th), H.R. 5801 (117th), H.R. 3173 (117th), H.R. 3990 (117th), H.R. 3353 (117th), H.R. 3 (117th), H.R. 8299 (117th), H.R. 1667 (117th), H.Res. 446 (117th), H.R. 7667 (117th)

Budget/Appropriations BUD

- HR 1319, "The American Rescue Plan Act of 2021", regarding all provisions - Issues related to NIH Appropriations (LHHS) - Issues related to HIV/AIDS Ryan White Appropriations (LHHS) and End the Epidemic - Issues related to funding for USAID Appropriations (SFOPS) - Issues pertaining to funding for programs that aim to improve maternal health - Issues pertaining to cross cutting health system strengthening - Issues related to FDA Appropriations - Issues related to contact lenses (FSGG)

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DEANA MCRAE —
ABIGAIL PINKELE —
MEGHAN DRENAN STONE —
KELLY WATERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Consumer Issues/Safety/Products CSP

- HR 2116, "Creating a Respectful and Open World for Natural Hair (CROWN ACT)", regarding all provisions - S 936, "INFORM Consumers Act", regarding all provisions - HR 3429/S 1843, "SHOP SAFE Act", regarding all provisions - S 3416, "Protecting Patients from Counterfeit Medical Devices Act", a bill to expand the enforcement authority of the FDA with respect to counterfeit devices - HR 6207/S 3357, "Humane Cosmetics Act", regarding all provisions - Issues related to ingredient safety - Issues related to animal testing and consumer products - Issues related to counterfeit consumer products - Issues related to brand protection - Issues related to e-Commerce

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
DARREL C JODREY —
ROBERTO SADA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3429 (117th), H.R. 2116 (117th), H.R. 6207 (117th)

Environment/Superfund ENV

- HR 4800/S 2546, "Reef Safe Act", regarding all provisions - Issues related to environmental sustainability - Issues related to recycling and plastics - Issues related to coral reefs - Issues related to clean energy

LobbyistCovered position, as disclosed
DARREL C JODREY —
DEANA MCRAE —
ROBERTO SADA —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4800 (117th)

Taxation/Internal Revenue Code TAX

- HR 5214, regarding expenditures from HSAs, FSAs, and health reimbursement arrangements for dietary supplements - Issues related to Health Spending Accounts & Flexible Spending Accounts - Issues related to corporate tax provisions of reconciliation bill - U.S. Treasury policy and negotiating positions related to tax at the Organisation for Economic Co-operation and Development ("OECD") - Issues related to US Treasury implementation of new corporate alternative minimum tax

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5214 (117th)

Trade (domestic/foreign) TRD

- HR 2884/S 1435, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act, regarding all provisions - Issues related to mandatory supply chain requirements, including under "Buy America" - Issues related to waiver of WTO TRIPS related to COVID response

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2884 (117th)

Science/Technology SCI

- Issues related to data privacy

LobbyistCovered position, as disclosed
LEIF BRIERLEY —
ROBERTO SADA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Civil Rights/Civil Liberties CIV

- HR 5, "Equality Act", regarding all provisions - S 264, "Dream Act of 2021", regarding all provisions - HR 4, "The John Lewis Voting Rights Advancement Act", issues relating to voting rights

LobbyistCovered position, as disclosed
LARRY CAMM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5 (117th), H.R. 4 (117th)

Bankruptcy BNK

- HR 4777/S 2497, "Nondebtor Release Prohibition Act of 2021", regarding all provisions - HR 2096/S 2472, "Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act", regarding all provisions - Issues related to corporate Chapter 11 bankruptcy filings and divisive mergers

LobbyistCovered position, as disclosed
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2096 (117th), H.R. 4777 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.